<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(AMENDMENT NO. 4)*
COLORADO MEDTECH, INC.
----------------------
(Name of Issuer)
Common Stock, No Par Value
--------------------------
Title of Class of Securities
19652U 10 4
------------
(CUSIP Number)
T. Richard Riney, Vice President and General Counsel, Ventas, Inc., 3300 Aegon
Center, 400 West Market Street, Louisville, Kentucky 40202 (502) 596-7300
----------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
April 30, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See (S)240.13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 19652U 10 4 SCHEDULE 13D Page 2 of 7 Pages
- --------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS Ventas, Inc. (formerly Vencor, Inc.)
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
61-1055020
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
Not applicable
(a)
----
(b)
----
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
Not applicable.
- --------------------------------------------------------------------------------
5. CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)
Not applicable.
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY (7) SOLE VOTING POWER
OWNED BY EACH REPORTING PERSON -0-
WITH
(8) SHARED VOTING POWER
-0-
(9) SOLE DISPOSITIVE POWER
-0-
(10) SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON -0-
- --------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (See instructions)
Not applicable
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
-0-
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON (See instructions)
CO
<PAGE>
CUSIP No. 19652U 10 4 Page 3 of 7 Pages
AMENDMENT NO. 4
TO
SCHEDULE 13D
OF VENTAS, INC.
This Amendment No. 4 amends and supplements the Statement on Schedule 13D,
dated December 3, 1993, Amendment No. 1 to Schedule 13D, dated May 13, 1994,
Amendment No. 2 to Schedule 13D, dated July 11, 1994, and Amendment No. 3 to
Schedule 13D, dated May 27, 1997, filed by Ventas, Inc., (formerly Vencor,
Inc.), with respect to the common stock, no par value, of Colorado MEDtech, Inc.
Such Schedule 13D is hereby amended to add or replace information as specified
below to the items indicated. This Amendment is being filed to indicate that
Ventas no longer beneficially owns any securities of the Issuer.
ITEM 1. SECURITY AND ISSUER.
--------------------
This Schedule 13D relates to shares of common stock, no par value per share
(the "Common Stock"), of Colorado MEDtech, Inc. ("Issuer"). The principal
executive offices of the Issuer are located at 6175 Longbow Drive, Boulder,
Colorado 80301.
ITEM 2. IDENTITY AND BACKGROUND.
------------------------
(a) This Amendment No. 4 to Schedule 13D is being filed by Ventas, Inc., a
Delaware corporation ("Ventas").
(b) The address of the principal business and the principal office of
Ventas is 3300 Aegon Center, 400 West Market Street, Louisville, Kentucky 40202.
The principal business of Ventas is real estate holdings.
(c) The name, business address, principal occupation or employment of each
director and executive officer of Ventas is set forth in the table below.
OFFICE AND
NAME PRINCIPAL OCCUPATION BUSINESS ADDRESS
---- -------------------- ----------------
W. Bruce Lunsford Chairman of the Board, 3300 Aegon Center
and Chief Executive Officer of 400 West Market Street
Ventas; Director of Ventas Louisville, KY 40202
<PAGE>
CUSIP No. 19652U 10 4 Page 4 of 7 Pages
Thomas T. Ladt President and Chief Operating 3300 Aegon Center
Officer of Ventas; Director of 400 West Market Street
Ventas Louisville, KY 40202
T. Richard Riney Vice President and General 3300 Aegon Center
Counsel of Ventas 400 West Market Street
Louisville, KY 40202
Walter F. Beran Chairman of Pacific Alliance 515 South Flower Street
Group, a merger and acquisition Los Angeles, CA 90071
services firm; Director of Ventas
Greg D. Hudson President of Hudson Chevrolet- Highway 41A North
Oldsmobile, Inc.; Director of Providence, KY 42450
Ventas
<PAGE>
CUSIP No. 19652U 10 4 Page 5 of 7 Pages
Ronald G. Geary President and Chief Executive 10140 Linn Station Road
Officer of Res-Care, Inc.; Louisville, KY 40223
Director of Ventas
R. Gene Smith Chairman of the Board of Taco 3600 National City Tower
Tico, Inc., an operator of 101 South Fifth Street
Mexican fast-food restaurants; Louisville, KY 40202
Managing General Partner of
Direct Programming Services, a
marketer of direct broadcast
satellite television services
since 1993; Director and Vice
Chairman of Ventas
(d) Each of the above listed directors and executive officers of Ventas is
a United States citizen.
(e) Neither Ventas nor any of its respective directors or executive
officers have, during the last five years, been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors), nor are any
of them subject to a judgment, decree or final order enjoining future violations
of, or prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such laws.
<PAGE>
CUSIP No. 19652U 10 4 Page 6 of 7 Pages
ITEM 3. SOURCE AND AMOUNTS OF FUNDS OR OTHER CONSIDERATION.
---------------------------------------------------
Not Applicable.
ITEM 4. PURPOSE OF TRANSACTION.
-----------------------
Not Applicable.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
-------------------------------------
On April 30, 1998, Ventas (formerly Vencor, Inc.) completed a corporate
reorganization in which it transferred all of the securities of the Issuer held
by it to Vencor, Inc. (formerly Vencor Healthcare, Inc.) ("New Vencor"). At the
time of the transfer, New Vencor was a wholly owned subsidiary of Ventas.
Following this transfer, Ventas distributed all of the stock of New Vencor to
the common stockholders of Ventas. Ventas ceased to be a reporting person on
April 30, 1998.
<PAGE>
CUSIP No. 19652U 10 4 Page 7 of 7 Pages
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
---------------------------------------------------------------------
TO SECURITIES OF THE ISSUER.
- ----------------------------
None
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
---------------------------------
None
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date: May 6, 1998
VENTAS, INC.
By: /s/ W. Bruce Lunsford
----------------------------
W. Bruce Lunsford, Chairman of the Board
and Chief Executive Officer
